ClinicalTrials.gg
RecruitingNCT06891807RobARUpdated Mar 24, 2025

Comparison of Image Based Robotic Total Knee Arthroplasty vs Imageless Augmented Reality Assisted Total Knee Arthroplasty

An interventional study of Robotics Assisted TKA and Augmented Reality assisted TKA in Knee Osteoarthritis, Total Knee Arthroplasty\(TKA\) and Total Knee Replacement Surgery, sponsored by Medisch Centrum Latem. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by Medisch Centrum Latem · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jul 2024, registered Dec 2024).
  • Started Jul 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 46 studies in Osteoarthritis, Knee with a site in Belgium — 6 open to participants now, 11 under way, none of them phase 3. Osteoarthritis, Knee · Belgium.

Planned enrollment
9th of 38
250 · median 86
Started
2024
with 1 other
No phase
25 of 46
6 open now
Primary completion
2027-10
later than 8 of 10 live
Registered
41st of 46
by date
Lead sponsor
2 of 46
Medisch Centrum Latem

Among the 46 studies in Osteoarthritis, Knee with a site in Belgium, this one is the 9th largest by planned enrollment of the 38 interventional ones that give a count, is one of 2 that started in 2024, is one of 25 with no phase, reaches primary completion later than 8 of the 10 other live ones, and was the 41st registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

6 of the 46 studies in Osteoarthritis, Knee with a site in Belgium are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Osteoarthritis, Knee with a site in Belgium, or all of them as a file.
02

Study summary

This study compares the accuracy of two different techniques in placing a total knee replacement. In one technique, accurate instrument placement is facilitated by a robot, and in the other technique, augmented reality is used for correct instrument placement. Both surgical techniques are already commonly used. During both the robotic technique and the augmented reality technique, the additional information (angles - axes) obtained during the operation is used to optimize the placement of the various prosthesis components.

Patients that were recently diagnosed with advanced osteoarthritis of the knee can participate in this study. This means that the cartilage of the knee is affected by wear and tear. This causes pain, stiffness and swelling resulting in reduced mobility. When non-operative treatments are insufficient in treating the osteoarthritis, surgery is proposed wherein a knee arthroplasty is performed.

The goal of this study is to further optimize and personalize patient care. Additionally, the aim of the study is to investigate whether both techniques are equivalent in optimally placing the prosthesis and whether both techniques lead to comparable results.

03

Conditions studied

  • Knee Osteoarthritis
  • Total Knee Arthroplasty\(TKA\)
  • Total Knee Replacement Surgery

Keywords

  • Total Knee Arthroplasty (TKA)
  • Knee Osteoarthritis
  • Assistive Technologies
  • Robotics
  • Augmented Reality
04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects from 18 years up to 85 years old
  • Patients eligible and planned for a primary Total Knee Arthroplasty
  • Patients willing to sign the form (ICF) for participating in this study
  • Indication of surgery is primary osteoarthritis

Exclusion criteria

Exclusion Criteria:

  • Revision knee surgery
  • Other medical conditions contributing to the rehabilitation process of the TKA according to the surgeon, such as Parkinson's Disease, dementia, multiple sclerosis and cerebral vascular accident
  • The patient received a TKA within the last three months or has a TKA planned in the next three months, for the contralateral knee
  • Patient is participating in another clinical trial
  • Patient is not able to understand Dutch, French or English
  • Patients who did not meet all of the inclusion criteria
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Active comparator
    Skywalker

    SkywalkerTM Robotics Assisted TKA using Evolution Medial Pivot Knee

    Device: Robotics Assisted TKA

  • Active comparator
    Pixee Knee+

    PIXEE Knee+ TKA using Evolution Medial Pivot Knee

    Device: Augmented Reality assisted TKA

Interventions

  • DeviceRobotics Assisted TKA

    Skywalker Robotics Assisted TKA using Evolution Medial Pivot Knee

    Also known as: Skywalker Robotics Assisted TKA

  • DeviceAugmented Reality assisted TKA

    Pixee Knee+ assisted TKA using Evolution Medial Pivot Knee

    Also known as: Pixee Knee+ TKA

06

What researchers measure

Primary outcomes

  1. radiographic alignment and positioning of the implant on full-leg standing X-Rays

    To evaluate the radiographic alignment and positioning of the implant on full-leg standing X-Rays at a minimum of 1 year follow up between two TKA assistive technologies. These results will be compared with the intraoperative settings for alignment and positioning of the implant.

    Time frame: 1 year follow-up

Secondary outcomes

  1. Safety and clinical outcomes of assistive TKA technologies

    Percentage change from baseline in activity parameters measured by a wearable device and clinical status measured by patient reported outcome measurements (PROM) at 6 weeks, 3 months, 6 months, 1 year and 2 years after TKA surgery. Safety will be assessed based on the incidence of treatment-related complications (e.g., wound complications, infection, nerve injury, peri-prosthetic fracture, urinary tract infection, deep vein thrombosis and pulmonary embolism ) as reported by patients and documented in medical records.

    Time frame: 2 year follow-up

  2. Activity parameters

    Percentage change from baseline in activity parameters (e.g., step count, activity types, amount of activities) measured by a wearable device, daily questionnaires and measured by the UCLA activity score at 6 weeks, 3 months, 6 months, 1 year and 2 years after TKA surgery.

    Time frame: 2 year follow-up

07

Study locations

1 of 1 sites recruiting
  • Medisch Centrum Latem
    Sint-Martens-Latem, Oost-Vlaanderen 9830, Belgium
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Oct 2027, 38 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 38 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2024
First posted
Mar 24, 2025
StartActual
Jul 18, 2024
Primary completionEst.
Oct 1, 2027
CompletionEst.
Oct 1, 2027
Last update
Mar 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06891807
Lead sponsor
Medisch Centrum Latem
Responsible party
Philippe Van Overschelde (Dr. Philippe Van Overschelde, MD, Orthopaedic Surgeon, Medisch Centrum Latem) — Principal investigator
First posted
Mar 24, 2025
Start date
Jul 18, 2024
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Mar 24, 2025

Study contacts

Philippe Van Overschelde, MD, MSc, MBA
Contact
secretariaat.heupknie@azmmsj.be
+9 220 88 68

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion